LIA
COCHW icon

Limestone Investment Advisors’s Envoy Medical Warrant COCHW Stock Holding History

Limestone Investment Advisors’s Portfolio COCHW Stock Details COCHW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.56K Hold
23,467
– – ﹤0.01% 395
2025
Q4 		$913 Hold
23,467
– – ﹤0.01% 441
2025
Q3 		$882 Hold
23,467
– – ﹤0.01% 520
2025
Q2 		$828 Buy
+23,467
New +$1.1K ﹤0.01% 479

Other funds holding COCHW

AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return
AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.2B AUM 41.22% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.7% 1-Year Est. Return

Limestone Investment Advisors's COCHW Position: Q1 2026 in Review

Limestone Investment Advisors held its Envoy Medical Warrant (COCHW) position steady in Q1 2026 at 23,467 shares worth $1.56K. The position accounts for ﹤0.01% of the portfolio, ranked #395.

Limestone Investment Advisors first reported a position in COCHW in Q2 2025 and has held it in 4 quarters since. 34 funds tracked by Wall St. Rank hold COCHW as of Q1 2026.

  • Limestone Investment Advisors held 23,467 shares of Envoy Medical Warrant worth $1.56K as of Q1 2026.
  • Limestone Investment Advisors left its Envoy Medical Warrant share count unchanged in Q1 2026.
  • Envoy Medical Warrant made up ﹤0.01% of Limestone Investment Advisors's portfolio in Q1 2026, its #395 holding.
  • Limestone Investment Advisors first reported a position in Envoy Medical Warrant in Q2 2025 and has held it in 4 quarters since.
  • 34 funds tracked by Wall St. Rank held Envoy Medical Warrant as of Q1 2026.

Based on Limestone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.